Dealing with Runaway Metastatic Disease
Oncotarget Press Releases,
Metastatic disease remains a major issue in daily practice in oncology because the outcome is still often fatal.
Metastatic disease remains a major issue in daily practice in oncology because the outcome is still often fatal.
A research paper has been published in Oncotarget titled, "INT-1B3, an LNP formulated miR-193a-3p mimic, promotes anti-tumor…
A new research paper was published inOncotarget'sVolume 15on July 12, 2024, entitled, INT-1B3, an LNP formulated miR-193a-3p…
A new research paper was published in Oncotarget's Volume 15 on July 12, 2024, entitled, "INT-1B3, an LNP formulated miR-193a-3p…
In this study, researchers Chantal L. Duurland, Thijs de Gunst, Harm C. den Boer, Marion T.J.
BUFFALO, NY- August 5, 2024 – A new research paper was published in Oncotarget’s Volume 15 on July 12, 2024, entitled, “INT-1B3…
A new research paper was published in Oncotarget's Volume 15 on July 12, 2024, entitled, "INT-1B3, an LNP formulated miR-193a-3p…
"INT-1B3 inhibited distant tumor metastasis and significantly prolonged survival.” image: Figure 7: Proposed mode of action of…
BUFFALO, NY- August 5, 2024 – A new research paper was published in Oncotarget's Volume 15 on July 12, 2024, entitled, "INT-1B3…
INT-1B3 inhibited distant tumor metastasis and significantly prolonged survival